Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Epstein-Barr virus infection (mmu05169)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
1700009N
14Rik
KLA  ATP  ATP+KLA
 NM_001081095 RIKEN cDNA 1700009N14 gene (1700009N14Rik), mRNA [NM_001081095] KLA .94 .99 1.04 1.06 1.04 1.00 .93
ATP 1.03 1.12 1.03 1.00 .89 1.04 .99
KLA/ATP .98 .94 1.05 1.03 .98 .95 1.02
AK031249
KLA  ATP  ATP+KLA
 AK031249 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930437C20 product:hypothetical protein, full insert sequence [AK031249] KLA .95 1.00 .98 .99 .96 1.01 1.07
ATP .92 1.02 1.10 1.15 1.22 1.03 1.01
KLA/ATP .96 .97 1.10 1.15 1.05 1.11 1.02
Akap8l
KLA  ATP  ATP+KLA
 NM_017476 A kinase (PRKA) anchor protein 8-like (Akap8l), mRNA [NM_017476] KLA .57 .59 .55 .60 .78 1.00 1.03
ATP 1.03 1.07 1.11 1.31 1.33 1.26 .94
KLA/ATP .63 .60 .58 .63 1.08 1.35 1.20
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
BB217526
KLA  ATP  ATP+KLA
 AK083592 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030051F04 product:unclassifiable, full insert sequence [AK083592] KLA 1.53 1.19 1.21 1.15 1.61 1.14 .87
ATP 1.33 1.11 1.15 1.11 2.06 1.48 1.13
KLA/ATP 1.36 1.18 1.61 1.37 1.77 1.10 1.13
BB483579
KLA  ATP  ATP+KLA
 BB483579 gb|BB483579 RIKEN full-length enriched, 13 days embryo lung Mus musculus cDNA clone D430021C16 3. [BB483579] KLA .99 1.01 .84 .82 .90 .92 .99
ATP .95 .84 .71 .82 .86 .89 .96
KLA/ATP .91 .84 .78 .79 .84 .96 .94
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Bst1
KLA  ATP  ATP+KLA
 NM_009763 bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763] KLA 2.26 2.15 2.90 3.73 4.89 5.96 6.57
ATP 1.05 1.06 1.31 1.52 1.57 4.31 4.76
KLA/ATP 2.29 2.31 3.10 2.98 3.09 5.35 13.91
Ccna1
KLA  ATP  ATP+KLA
 NM_007628 cyclin A1 (Ccna1), mRNA [NM_007628] KLA .97 .96 1.03 1.01 .97 .96 1.02
ATP .98 .99 1.00 1.01 .98 .95 .98
KLA/ATP 1.05 .96 1.01 1.04 .97 .92 1.01
Ccna2
KLA  ATP  ATP+KLA
 NM_009828 cyclin A2 (Ccna2), mRNA [NM_009828] KLA .28 .21 .19 .14 .09 .07 .06
ATP 1.17 1.11 1.03 1.01 .59 .20 .05
KLA/ATP .29 .22 .23 .21 .13 .08 .06
Cd19
KLA  ATP  ATP+KLA
 NM_009844 CD19 antigen (Cd19), mRNA [NM_009844] KLA 1.05 1.04 1.09 1.05 1.03 1.07 1.10
ATP 1.04 1.03 .99 1.07 .93 .97 .97
KLA/ATP 1.04 1.03 1.02 .97 1.01 1.00 1.08
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Cd40
KLA  ATP  ATP+KLA
 NM_170701 CD40 antigen (Cd40), transcript variant 3, mRNA [NM_170701] KLA 23.87 23.62 23.26 23.98 22.07 17.37 5.34
ATP 1.00 1.01 1.06 2.96 2.65 3.03 1.70
KLA/ATP 22.77 23.79 29.67 28.85 28.08 21.62 13.02
Cd44
KLA  ATP  ATP+KLA
 NM_009851 CD44 antigen (Cd44), transcript variant 1, mRNA [NM_009851] KLA 1.87 1.86 1.79 1.42 .99 .54 .67
ATP 1.05 1.16 1.24 1.67 1.79 1.37 .85
KLA/ATP 2.00 2.08 1.53 1.86 1.24 .89 .71
Cdc2a
KLA  ATP  ATP+KLA
 NM_007659 cell division cycle 2 homolog A (S. pombe) (Cdc2a), mRNA [NM_007659] KLA .72 .68 .65 .58 .58 .59 .48
ATP 1.01 1.05 1.21 1.06 .83 .77 .51
KLA/ATP .68 .63 .79 .70 .59 .59 .51
Cdk2
KLA  ATP  ATP+KLA
 NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73
ATP 1.02 1.14 .91 .92 .68 .71 .65
KLA/ATP .67 .64 .64 .64 .61 .74 .62
Cdkn1a
KLA  ATP  ATP+KLA
 NM_007669 cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a), transcript variant 1, mRNA [NM_007669] KLA 4.72 4.90 4.96 3.73 2.11 1.14 1.02
ATP 1.14 1.52 .95 1.69 1.47 2.21 .50
KLA/ATP 5.99 7.08 3.86 6.37 3.00 2.55 2.05
Cdkn1b
KLA  ATP  ATP+KLA
 NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97
ATP .99 1.09 .97 1.06 1.48 .94 .91
KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Cr2
KLA  ATP  ATP+KLA
 NM_007758 complement receptor 2 (Cr2), mRNA [NM_007758] KLA .98 .98 .99 1.01 1.00 .99 1.02
ATP 1.03 .99 .94 1.01 1.02 .95 .99
KLA/ATP 1.04 1.07 1.07 1.08 1.06 1.04 .93
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Csnk2a1
KLA  ATP  ATP+KLA
 NM_007788 casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] KLA 1.36 1.39 1.19 1.34 1.32 1.74 1.86
ATP .92 .88 1.13 .86 1.12 2.50 1.99
KLA/ATP 1.19 1.24 1.35 1.03 1.16 2.09 2.88
Csnk2a2
KLA  ATP  ATP+KLA
 NM_009974 casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] KLA 1.46 1.53 1.70 1.47 1.32 1.32 1.17
ATP 1.00 1.11 1.17 1.33 1.71 2.03 1.06
KLA/ATP 1.58 1.67 1.69 2.00 2.20 2.44 1.68
Csnk2b
KLA  ATP  ATP+KLA
 NM_009975 casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] KLA 1.19 1.10 1.12 1.13 1.20 1.28 1.25
ATP 1.12 1.03 1.04 1.07 1.20 1.27 1.09
KLA/ATP 1.15 1.20 1.25 1.13 1.44 1.34 1.35
Ddx58
KLA  ATP  ATP+KLA
 NM_172689 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58), mRNA [NM_172689] KLA 8.80 9.12 9.70 9.96 9.92 7.85 5.67
ATP 1.06 .89 .97 .89 .80 3.03 3.67
KLA/ATP 9.18 9.23 10.31 9.25 7.29 6.93 8.99
EG629860
KLA  ATP  ATP+KLA
 M17953 gb|Mouse Ig rearranged H-chain V-region mRNA VJ1 [M17953] KLA .96 1.05 1.03 1.08 1.08 1.02 .98
ATP .97 .99 1.05 1.10 .95 .94 .91
KLA/ATP .96 .94 .97 1.04 .97 1.01 .89
Eif2ak1
KLA  ATP  ATP+KLA
 AK032508 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574E03 product:EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 (EC 2.7.1.-) (HEME-REGULATED EUKARYOTIC INITIATION FACTOR EIF-2-ALPHA KINASE) (HEME-R KLA .65 .66 .65 .67 .67 .85 1.06
ATP 1.07 1.13 1.10 1.03 .70 .63 .72
KLA/ATP .68 .73 .70 .67 .65 .66 .47
Eif2ak1
KLA  ATP  ATP+KLA
 NM_013557 eukaryotic translation initiation factor 2 alpha kinase 1 (Eif2ak1), mRNA [NM_013557] KLA 1.16 1.19 1.32 1.21 1.58 1.51 1.59
ATP 1.19 1.27 .93 1.28 1.02 1.53 1.60
KLA/ATP 1.36 1.50 1.16 1.38 1.12 1.79 2.42
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Eif2ak3
KLA  ATP  ATP+KLA
 AK041698 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630030N06 product:unclassifiable, full insert sequence. [AK041698] KLA .79 .77 .83 .80 .93 .87 .85
ATP .82 .82 .82 .92 .88 .85 .91
KLA/ATP .77 .76 .78 .80 .84 .86 .81
Eif2ak3
KLA  ATP  ATP+KLA
 NM_010121 eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), mRNA [NM_010121] KLA .28 .28 .27 .29 .38 .36 .47
ATP 1.17 1.04 .62 .48 .54 .48 .67
KLA/ATP .29 .30 .26 .26 .34 .37 .32
Eif2ak4
KLA  ATP  ATP+KLA
 AF193344 GCN2gamma mRNA, complete cds [AF193344] KLA .78 .78 .66 .72 .79 .83 1.05
ATP .97 1.06 .97 .97 .98 .86 .94
KLA/ATP .81 .73 .62 .84 .81 .88 .90
Eif2ak4
KLA  ATP  ATP+KLA
 NM_013719 eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4), mRNA [NM_013719] KLA .60 .55 .49 .54 .59 .67 .91
ATP 1.11 1.18 1.00 .94 1.33 .90 .98
KLA/ATP .59 .54 .56 .58 .90 .86 .86
Entpd1
KLA  ATP  ATP+KLA
 NM_009848 ectonucleoside triphosphate diphosphohydrolase 1 (Entpd1), mRNA [NM_009848] KLA .75 .72 .77 .64 .57 .42 .24
ATP 1.21 1.24 1.23 1.59 1.14 .70 1.33
KLA/ATP .87 .91 .78 1.03 .64 .66 1.14
Entpd3
KLA  ATP  ATP+KLA
 NM_178676 ectonucleoside triphosphate diphosphohydrolase 3 (Entpd3), mRNA [NM_178676] KLA .98 1.01 .99 .97 1.05 1.00 .99
ATP 1.02 1.02 .99 1.07 1.02 .99 1.28
KLA/ATP 1.00 1.03 1.00 1.06 1.07 1.11 1.27
Entpd8
KLA  ATP  ATP+KLA
 NM_028093 ectonucleoside triphosphate diphosphohydrolase 8 (Entpd8), mRNA [NM_028093] KLA 1.05 .98 1.07 .98 .96 .99 1.01
ATP 1.05 1.01 .91 1.04 1.07 1.01 .90
KLA/ATP .97 1.07 1.04 1.01 .99 1.07 .99
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Fcer2a
KLA  ATP  ATP+KLA
 NM_013517 Fc receptor, IgE, low affinity II, alpha polypeptide (Fcer2a), mRNA [NM_013517] KLA .99 .99 1.03 .98 .92 1.00 .95
ATP .96 .96 .97 1.02 1.00 .98 .97
KLA/ATP .99 1.04 1.02 1.01 .95 .92 .95
Fgr
KLA  ATP  ATP+KLA
 NM_010208 Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog (Fgr), mRNA [NM_010208] KLA 2.84 2.96 3.09 3.96 5.21 4.30 5.46
ATP 1.01 1.01 1.09 1.14 1.03 1.11 1.37
KLA/ATP 2.68 2.99 2.38 2.68 1.80 1.28 1.88
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Gtf2b
KLA  ATP  ATP+KLA
 NM_145546 general transcription factor IIB (Gtf2b), mRNA [NM_145546] KLA 2.06 1.99 1.46 1.18 .94 .88 .85
ATP 1.00 .93 1.09 1.23 2.23 2.17 1.20
KLA/ATP 1.92 1.96 2.20 1.95 2.26 2.78 1.44
Gtf2e1
KLA  ATP  ATP+KLA
 NM_028812 general transcription factor II E, polypeptide 1 (alpha subunit) (Gtf2e1), mRNA [NM_028812] KLA 1.19 1.16 .97 .85 .75 .89 .98
ATP .91 .85 .88 .53 .45 1.05 .94
KLA/ATP 1.05 1.03 .91 .63 .45 .75 .72
Gtf2e2
KLA  ATP  ATP+KLA
 NM_026584 general transcription factor II E, polypeptide 2 (beta subunit) (Gtf2e2), mRNA [NM_026584] KLA .89 .90 1.13 1.14 1.00 1.06 .99
ATP 1.02 .98 1.34 1.07 .81 1.65 1.22
KLA/ATP .88 1.01 1.43 1.08 1.01 1.33 1.03
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Hdac1
KLA  ATP  ATP+KLA
 U80780 putative histone deacetylase (HD1) mRNA, partial cds [U80780] KLA 2.59 2.39 2.48 2.74 3.36 2.56 1.22
ATP 1.13 1.26 1.18 1.08 .85 1.29 1.15
KLA/ATP 2.15 2.27 2.64 2.57 1.78 1.89 2.31
Hdac2
KLA  ATP  ATP+KLA
 AK051753 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130072G11 product:histone deacetylase 2, full insert sequence [AK051753] KLA .97 .97 .90 .96 1.02 .93 .96
ATP 1.02 1.03 .98 .96 .96 .90 1.05
KLA/ATP 1.00 .96 .87 .99 .92 1.00 .95
Hdac2
KLA  ATP  ATP+KLA
 NM_008229 histone deacetylase 2 (Hdac2), mRNA [NM_008229] KLA 1.27 1.35 1.33 1.18 1.03 .75 1.10
ATP .95 1.05 .79 .96 .82 .85 .81
KLA/ATP 1.28 1.43 .93 1.10 .82 .73 .60
Hdac4
KLA  ATP  ATP+KLA
 NM_207225 histone deacetylase 4 (Hdac4), mRNA [NM_207225] KLA .57 .59 .47 .49 .48 .54 .71
ATP 1.00 1.01 .84 1.35 1.05 1.51 .65
KLA/ATP .56 .54 .51 .69 .67 1.29 1.02
Hdac5
KLA  ATP  ATP+KLA
 NM_001077696 histone deacetylase 5 (Hdac5), transcript variant 1, mRNA [NM_001077696] KLA .41 .37 .37 .42 .52 .82 .76
ATP .95 .91 1.11 1.19 .66 .77 1.09
KLA/ATP .40 .36 .43 .50 .68 1.09 1.42
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Hspb1
KLA  ATP  ATP+KLA
 NM_013560 heat shock protein 1 (Hspb1), mRNA [NM_013560] KLA 1.63 1.62 1.69 1.84 1.65 1.81 1.21
ATP 1.03 1.21 6.84 15.12 14.19 14.09 5.57
KLA/ATP 1.71 1.77 3.66 12.62 12.11 12.52 7.66
Hspb2
KLA  ATP  ATP+KLA
 NM_024441 heat shock protein 2 (Hspb2), mRNA [NM_024441] KLA 1.01 1.06 .95 1.04 1.01 1.01 .93
ATP .99 1.02 .97 .94 .93 .95 1.01
KLA/ATP .99 1.00 1.04 1.01 .92 .95 1.01
Icam1
KLA  ATP  ATP+KLA
 BC008626 intercellular adhesion molecule, mRNA (cDNA clone MGC:6195 IMAGE:3588949), complete cds [BC008626] KLA 36.67 32.93 28.63 27.91 14.65 8.16 4.15
ATP .96 .88 1.50 3.88 4.98 3.90 1.01
KLA/ATP 32.58 31.60 42.74 32.60 26.00 13.02 6.01
Icam1
KLA  ATP  ATP+KLA
 NM_010493 intercellular adhesion molecule 1 (Icam1), mRNA [NM_010493] KLA 15.66 15.20 12.96 12.31 9.39 6.17 3.81
ATP .96 1.06 1.21 4.19 4.33 3.16 1.06
KLA/ATP 14.31 15.46 17.84 17.60 13.77 8.36 5.42
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Igh-VJ55
8
KLA  ATP  ATP+KLA
 AY547436 immunoglobulin heavy chain VDJ region mRNA, partial cds [AY547436] KLA 1.06 1.05 1.01 .93 1.03 .96 .93
ATP .99 1.00 1.06 .95 .96 1.06 1.05
KLA/ATP .98 .94 1.07 .95 .97 .99 1.02
Igh-VJ55
8
KLA  ATP  ATP+KLA
 CA578712 gb|K0727F04-5N NIA Mouse Hematopoietic Stem Cell (Lin- [CA578712] KLA .99 .94 1.01 1.10 .93 .97 .92
ATP .93 1.04 1.01 .98 1.05 .96 .95
KLA/ATP .99 .95 .95 .98 1.02 .98 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103412 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHA] [ENSMUST00000103412] KLA 1.01 .97 1.20 1.01 .98 1.44 1.24
ATP .99 .98 1.07 1.03 1.00 1.01 1.21
KLA/ATP .99 1.02 .96 1.03 .97 1.13 1.30
Igh-VJ55
8
KLA  ATP  ATP+KLA
 ENSMUST00000103413 ens|Immunoglobulin heavy chain C gene segment [Source:IMGT/GENE_DB;Acc:IGHE] [ENSMUST00000103413] KLA 1.00 .99 1.06 1.06 .99 1.03 1.02
ATP 1.08 1.06 1.06 1.06 1.02 1.06 .95
KLA/ATP 1.00 1.04 1.09 1.02 1.06 1.02 .95
Igh-VJ55
8
KLA  ATP  ATP+KLA
 U39781 J558+ IgM heavy chain mRNA, hybridoma clone ME2B7, partial cds. [U39781] KLA .93 .89 .98 .97 1.03 1.00 .94
ATP 1.04 1.02 1.08 .94 .93 .90 .79
KLA/ATP .88 .89 .97 .93 .88 .92 .82
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il10
KLA  ATP  ATP+KLA
 NM_010548 interleukin 10 (Il10), mRNA [NM_010548] KLA 17.59 18.64 22.22 23.06 11.83 8.27 2.07
ATP 1.86 3.22 7.72 20.51 25.86 8.38 1.01
KLA/ATP 17.91 23.49 34.53 34.48 20.98 12.03 8.17
Il10ra
KLA  ATP  ATP+KLA
 NM_008348 interleukin 10 receptor, alpha (Il10ra), mRNA [NM_008348] KLA 4.92 4.49 5.29 3.79 4.00 3.02 1.77
ATP 1.15 1.13 1.19 1.16 2.95 1.73 .80
KLA/ATP 5.70 4.92 6.13 3.01 4.78 3.11 2.37
Il10rb
KLA  ATP  ATP+KLA
 AF440787 C57BL [AF440787] KLA .71 .67 .65 .81 1.20 1.50 1.07
ATP 1.03 1.04 1.01 1.12 .84 .85 1.52
KLA/ATP .67 .68 .70 .82 .92 1.23 1.83
Il10rb
KLA  ATP  ATP+KLA
 AK018347 12 days embryo female ovary cDNA, RIKEN full-length enriched library, clone:6620401D04 product:unclassifiable, full insert sequence. [AK018347] KLA .89 1.00 1.05 1.07 1.29 1.12 .96
ATP .91 .73 1.23 1.43 .98 1.06 .92
KLA/ATP .86 .83 1.13 1.41 1.24 1.11 1.13
Irak1
KLA  ATP  ATP+KLA
 NM_008363 interleukin-1 receptor-associated kinase 1 (Irak1), mRNA [NM_008363] KLA .67 .67 .64 .56 .58 .58 .84
ATP 1.02 1.10 .94 1.14 .81 .54 .87
KLA/ATP .72 .72 .57 .67 .51 .43 .62
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Itgal
KLA  ATP  ATP+KLA
 AK156251 activated spleen cDNA, RIKEN full-length enriched library, clone:F830013L17 product:integrin alpha L, full insert sequence [AK156251] KLA 5.36 5.78 4.86 5.55 7.02 8.63 11.12
ATP .99 1.17 1.22 1.57 1.35 1.95 3.79
KLA/ATP 5.42 5.89 4.95 5.91 3.96 4.93 10.15
Itgal
KLA  ATP  ATP+KLA
 NM_008400 integrin alpha L (Itgal), mRNA [NM_008400] KLA 4.48 5.17 5.28 5.82 7.82 8.09 16.96
ATP 1.03 1.06 1.24 1.44 1.34 2.02 4.59
KLA/ATP 4.71 5.63 5.49 5.60 3.66 4.65 17.76
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
LOC10004
6483
KLA  ATP  ATP+KLA
 XM_001476285 ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] KLA .97 .94 .94 .88 .84 .76 .88
ATP 1.06 1.04 .89 .82 .87 .70 .56
KLA/ATP 1.03 1.00 .88 .75 .73 .66 .43
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Lyn
KLA  ATP  ATP+KLA
 NM_010747 Yamaguchi sarcoma viral (v-yes-1) oncogene homolog (Lyn), transcript variant 2, mRNA [NM_010747] KLA 2.48 2.80 3.76 3.81 5.30 4.57 2.46
ATP 1.06 1.18 .82 .97 .74 1.45 1.21
KLA/ATP 2.82 3.16 2.24 2.87 1.73 1.80 2.63
Map2k3
KLA  ATP  ATP+KLA
 NM_008928 mitogen-activated protein kinase kinase 3 (Map2k3), mRNA [NM_008928] KLA .88 .88 .73 .65 .99 1.34 .92
ATP 1.04 1.09 .89 1.62 1.93 1.75 1.17
KLA/ATP 1.00 .92 .66 1.21 1.80 2.24 2.10
Map2k4
KLA  ATP  ATP+KLA
 NM_009157 mitogen-activated protein kinase kinase 4 (Map2k4), mRNA [NM_009157] KLA 3.67 3.75 4.23 3.90 3.30 1.87 1.12
ATP 1.05 1.11 1.04 .93 1.16 2.62 1.02
KLA/ATP 3.70 4.13 3.27 4.13 2.98 3.03 1.82
Map2k6
KLA  ATP  ATP+KLA
 NM_011943 mitogen-activated protein kinase kinase 6 (Map2k6), mRNA [NM_011943] KLA .68 .67 .64 .67 .62 .59 .61
ATP 1.02 1.12 1.04 1.10 .79 .61 .61
KLA/ATP .73 .69 .71 .74 .66 .62 .98
Map2k7
KLA  ATP  ATP+KLA
 BC070467 mitogen activated protein kinase kinase 7, mRNA (cDNA clone MGC:96654 IMAGE:30615302), complete cds [BC070467] KLA .77 .79 .88 .77 .97 .96 1.27
ATP 1.11 1.26 .93 1.19 1.13 1.45 1.16
KLA/ATP .89 .88 .59 .89 .86 1.32 1.28
Map2k7
KLA  ATP  ATP+KLA
 NM_001042557 mitogen-activated protein kinase kinase 7 (Map2k7), transcript variant 1, mRNA [NM_001042557] KLA .96 .95 1.02 .96 .95 1.09 1.19
ATP 1.02 1.07 .88 .97 .93 1.10 1.17
KLA/ATP 1.01 .99 .80 .87 .76 1.21 1.16
Map3k14
KLA  ATP  ATP+KLA
 NM_016896 mitogen-activated protein kinase kinase kinase 14 (Map3k14), mRNA [NM_016896] KLA .32 .30 .40 .52 1.08 1.14 .94
ATP 1.18 1.24 1.13 .85 .82 .84 .99
KLA/ATP .33 .30 .34 .50 1.02 .84 1.43
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Map3k7ip
1
KLA  ATP  ATP+KLA
 NM_025609 mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (Map3k7ip1), mRNA [NM_025609] KLA .32 .30 .35 .56 .67 .82 .76
ATP .95 .81 .80 .42 .35 .40 .80
KLA/ATP .33 .30 .37 .20 .45 .62 .65
Map3k7ip
2
KLA  ATP  ATP+KLA
 AK086230 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930015C19 product:inferred: Mus musculus, Similar to TAK1-binding protein 2; KIAA0733 protein, clone MGC:8010 IMAGE:3586132, mRNA, complete cds, full insert sequence. [A KLA 1.14 1.02 1.07 1.03 1.13 1.02 .96
ATP 1.00 .88 .92 .90 1.06 .96 .94
KLA/ATP 1.05 1.00 .90 .98 1.02 .97 .97
Map3k7ip
2
KLA  ATP  ATP+KLA
 NM_138667 mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (Map3k7ip2), mRNA [NM_138667] KLA 3.43 3.22 3.19 2.41 2.13 1.51 1.10
ATP 1.08 1.08 .86 .81 1.30 1.32 1.02
KLA/ATP 3.34 3.66 3.00 2.58 1.80 1.52 1.61
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk11
KLA  ATP  ATP+KLA
 NM_011161 mitogen-activated protein kinase 11 (Mapk11), mRNA [NM_011161] KLA 1.28 1.30 1.41 1.46 1.58 1.29 .98
ATP .96 .95 .89 .82 .79 1.09 .85
KLA/ATP 1.44 1.42 1.32 1.23 1.23 .74 .66
Mapk12
KLA  ATP  ATP+KLA
 NM_013871 mitogen-activated protein kinase 12 (Mapk12), mRNA [NM_013871] KLA .94 .86 .87 .81 .77 .68 .49
ATP .97 .83 .92 .90 .86 .90 .51
KLA/ATP .91 .89 .88 .85 1.12 1.14 .53
Mapk13
KLA  ATP  ATP+KLA
 NM_011950 mitogen-activated protein kinase 13 (Mapk13), mRNA [NM_011950] KLA 1.22 1.21 1.35 1.26 1.24 1.13 1.01
ATP 1.08 1.00 1.20 1.20 1.13 1.22 1.39
KLA/ATP 1.22 1.27 1.30 1.30 1.21 1.11 1.47
Mapk14
KLA  ATP  ATP+KLA
 NM_011951 mitogen-activated protein kinase 14 (Mapk14), mRNA [NM_011951] KLA .70 .70 .62 .54 .67 .88 1.11
ATP 1.03 .98 .87 .69 .48 .78 .66
KLA/ATP .74 .68 .52 .46 .38 .45 .62
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mdm2
KLA  ATP  ATP+KLA
 NM_010786 transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA [NM_010786] KLA 1.77 1.59 1.98 1.51 1.77 1.60 1.77
ATP 1.01 1.21 1.36 3.24 5.04 2.08 1.36
KLA/ATP 1.89 1.86 2.93 5.65 5.98 2.78 2.64
Mm.1233
KLA  ATP  ATP+KLA
 158508444 Unknown KLA .97 .97 .95 .98 1.04 1.00 .93
ATP 1.03 1.08 1.29 1.57 1.01 .96 1.21
KLA/ATP .97 1.00 1.58 1.65 .96 .91 .86
Mm.13849
KLA  ATP  ATP+KLA
 158937311 Unknown KLA 1.71 1.69 1.64 1.89 1.78 1.97 1.25
ATP 1.00 1.23 5.40 7.14 6.79 7.89 4.71
KLA/ATP 1.73 1.75 5.04 7.35 8.18 7.92 6.07
Mm.15898
1
KLA  ATP  ATP+KLA
 142388182 Unknown KLA .25 .22 .31 .50 .85 1.11 .83
ATP 1.02 .94 1.31 .76 .73 .96 .92
KLA/ATP .24 .22 .34 .38 1.16 .96 1.23
Mm.1741
KLA  ATP  ATP+KLA
 31982052 Unknown KLA 4.05 3.90 3.12 3.55 4.00 3.37 2.25
ATP 1.01 1.01 1.44 2.36 3.07 3.54 1.27
KLA/ATP 4.19 3.74 4.02 4.02 3.13 2.82 3.33
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.21511
5
KLA  ATP  ATP+KLA
 146149315 Unknown KLA .94 .93 .96 .95 .89 .95 1.08
ATP 1.02 .93 1.00 .83 .78 .92 1.58
KLA/ATP .90 .96 .93 .85 .77 .83 .83
Mm.22665
KLA  ATP  ATP+KLA
 118136294 Unknown KLA .27 .24 .24 .28 .40 .65 .62
ATP .91 .87 1.07 1.07 .55 .70 1.09
KLA/ATP .26 .24 .27 .33 .54 1.02 1.43
Mm.23522
KLA  ATP  ATP+KLA
 124487357 Unknown KLA 1.02 1.00 .97 .98 1.00 .96 .93
ATP .98 .99 1.06 .97 .94 1.00 1.03
KLA/ATP .94 1.01 1.03 1.01 1.04 1.02 1.01
Mm.23692
KLA  ATP  ATP+KLA
 164565453 Unknown KLA .83 .77 .72 .65 .61 .75 .80
ATP .77 .94 1.03 .63 .61 .74 .59
KLA/ATP .58 .78 .77 .52 .51 .56 .30
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.27166
5
KLA  ATP  ATP+KLA
 171542818 Unknown KLA 1.54 1.51 1.60 1.85 2.41 2.03 2.49
ATP 1.06 1.07 1.03 1.04 .88 1.05 1.11
KLA/ATP 1.61 1.54 1.31 1.32 1.16 1.00 1.23
Mm.27970
KLA  ATP  ATP+KLA
 13994135 Unknown KLA 1.06 1.11 1.16 1.07 1.11 1.08 .95
ATP 1.02 1.09 1.05 1.05 .94 1.16 1.32
KLA/ATP 1.10 1.19 1.11 1.04 1.08 1.02 1.33
Mm.27992
3
KLA  ATP  ATP+KLA
 56699422 Unknown KLA .96 .90 .93 .88 .86 .84 .91
ATP .97 1.02 1.03 .99 .91 .89 .90
KLA/ATP .90 .93 .93 .93 .90 .91 .81
Mm.3458
KLA  ATP  ATP+KLA
 119226250 Unknown KLA .85 .78 .75 .84 .74 .81 .79
ATP .97 .83 1.09 .93 2.03 1.96 .89
KLA/ATP .81 .72 .89 .63 1.72 1.77 .79
Mm.35584
KLA  ATP  ATP+KLA
 70909358 Unknown KLA .22 .25 .28 .33 .40 .77 .46
ATP 1.05 .96 1.08 .56 1.10 .79 .74
KLA/ATP .23 .25 .32 .25 .90 1.02 .60
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.41292
2
KLA  ATP  ATP+KLA
 145966829 Unknown KLA 3.65 3.76 3.75 3.79 3.42 1.75 1.10
ATP 1.11 1.17 1.04 .90 1.37 2.90 1.00
KLA/ATP 3.31 3.97 3.38 3.84 3.04 3.31 2.09
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.44463
KLA  ATP  ATP+KLA
 118129851 Unknown KLA 1.01 .98 .97 1.02 .93 1.06 1.05
ATP .97 1.01 1.04 1.06 1.02 1.08 .97
KLA/ATP 1.02 1.06 .95 1.04 1.09 1.14 1.03
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.47351
0
KLA  ATP  ATP+KLA
 162287332 Unknown KLA 4.46 4.82 5.29 4.00 2.26 1.25 1.10
ATP 1.24 1.72 1.02 2.08 1.66 2.53 .55
KLA/ATP 6.11 7.67 4.29 6.99 3.11 2.86 2.30
Mm.874
KLA  ATP  ATP+KLA
 6754317 Unknown KLA 24.98 24.87 26.43 39.61 12.88 8.64 1.63
ATP 1.97 3.50 11.05 28.47 38.30 10.44 .65
KLA/ATP 23.45 29.37 58.52 51.77 30.64 14.61 8.63
Myc
KLA  ATP  ATP+KLA
 NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33
ATP 1.05 1.09 1.72 4.41 1.28 .45 .76
KLA/ATP .37 .30 .44 1.23 .34 .17 .19
Ncor2
KLA  ATP  ATP+KLA
 NM_011424 nuclear receptor co-repressor 2 (Ncor2), mRNA [NM_011424] KLA .39 .37 .36 .35 .60 .99 .99
ATP 1.10 1.20 1.08 1.26 .64 .61 1.07
KLA/ATP .45 .41 .39 .44 .37 .63 .95
Nedd4
KLA  ATP  ATP+KLA
 NM_010890 neural precursor cell expressed, developmentally down-regulated gene 4 (Nedd4), mRNA [NM_010890] KLA 1.00 1.04 1.03 1.02 .85 .94 .95
ATP 1.04 1.05 1.03 1.06 1.01 .89 .80
KLA/ATP 1.04 .99 1.02 1.05 .99 .90 .82
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkb2
KLA  ATP  ATP+KLA
 NM_019408 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2), mRNA [NM_019408] KLA 7.31 7.92 7.95 6.42 6.41 4.42 2.81
ATP .99 .98 .72 1.48 2.80 5.31 1.44
KLA/ATP 8.25 7.93 6.51 7.68 5.08 4.38 4.86
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Nfkbie
KLA  ATP  ATP+KLA
 NM_008690 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon (Nfkbie), mRNA [NM_008690] KLA 5.87 5.26 4.28 4.30 4.38 3.56 2.69
ATP .92 1.04 1.55 1.83 3.57 8.04 2.35
KLA/ATP 5.07 5.19 5.86 4.34 3.56 8.64 9.00
Nup214
KLA  ATP  ATP+KLA
 NM_172268 nucleoporin 214 (Nup214), mRNA [NM_172268] KLA .99 .92 .96 .98 .91 1.07 1.09
ATP .96 1.01 1.19 1.15 1.09 1.13 1.01
KLA/ATP .93 1.00 1.12 .97 1.02 1.05 1.14
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Polr2a
KLA  ATP  ATP+KLA
 NM_009089 polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), mRNA [NM_009089] KLA 1.21 1.16 1.15 1.16 1.16 1.25 1.12
ATP 1.00 1.09 1.07 1.39 1.35 1.28 1.16
KLA/ATP 1.20 1.18 1.26 1.30 1.30 1.51 1.37
Polr2b
KLA  ATP  ATP+KLA
 NM_153798 polymerase (RNA) II (DNA directed) polypeptide B (Polr2b), mRNA [NM_153798] KLA .91 .91 .92 .73 .77 .80 .83
ATP 1.09 1.18 .96 .80 .64 .75 .93
KLA/ATP 1.01 .98 .74 .74 .53 .72 .71
Polr2c
KLA  ATP  ATP+KLA
 NM_009090 polymerase (RNA) II (DNA directed) polypeptide C (Polr2c), mRNA [NM_009090] KLA 1.45 1.41 1.48 1.33 1.24 1.24 1.34
ATP .97 1.07 1.01 1.06 1.09 1.27 1.13
KLA/ATP 1.48 1.46 1.34 1.46 1.27 1.50 1.26
Polr2d
KLA  ATP  ATP+KLA
 NM_027101 polymerase (RNA) II (DNA directed) polypeptide D (Polr2d), transcript variant 2, mRNA [NM_027101] KLA .89 .90 .80 .87 .86 .94 .99
ATP .95 .95 1.15 1.05 .93 1.45 .80
KLA/ATP .81 .88 .99 .96 .99 1.33 .89
Polr2e
KLA  ATP  ATP+KLA
 AK010567 ES cells cDNA, RIKEN full-length enriched library, clone:2410021N14 product:polymerase (RNA) II (DNA directed) polypeptide E, full insert sequence. [AK010567] KLA .67 .68 .68 .56 .58 .45 .67
ATP 1.14 1.18 1.05 1.26 .91 .63 .80
KLA/ATP .80 .77 .71 .81 .75 .50 .49
Polr2e
KLA  ATP  ATP+KLA
 NM_025554 polymerase (RNA) II (DNA directed) polypeptide E (Polr2e), mRNA [NM_025554] KLA .69 .74 .69 .61 .56 .49 .70
ATP 1.00 1.06 1.02 1.20 .88 .67 .73
KLA/ATP .79 .76 .72 .80 .77 .55 .45
Polr2f
KLA  ATP  ATP+KLA
 NM_027231 polymerase (RNA) II (DNA directed) polypeptide F (Polr2f), mRNA [NM_027231] KLA 1.01 .99 .92 .94 .86 .78 .84
ATP .94 1.00 1.18 1.34 1.14 .88 .91
KLA/ATP .96 1.07 1.23 1.38 1.16 .96 .70
Polr2g
KLA  ATP  ATP+KLA
 NM_026329 polymerase (RNA) II (DNA directed) polypeptide G (Polr2g), mRNA [NM_026329] KLA 2.39 2.22 2.36 2.22 1.69 1.12 1.08
ATP .93 .91 1.27 1.12 1.19 1.43 1.23
KLA/ATP 2.24 2.26 3.23 2.51 3.15 2.36 1.54
Polr2h
KLA  ATP  ATP+KLA
 NM_145632 polymerase (RNA) II (DNA directed) polypeptide H (Polr2h), mRNA [NM_145632] KLA .80 .76 .66 .62 .73 .87 1.14
ATP .90 .91 1.01 .99 1.10 1.32 .98
KLA/ATP .68 .72 .69 .65 .90 1.01 .62
Polr2i
KLA  ATP  ATP+KLA
 NM_027259 polymerase (RNA) II (DNA directed) polypeptide I (Polr2i), mRNA [NM_027259] KLA .67 .69 .68 .78 .80 .90 .99
ATP .98 .88 1.10 .84 .77 1.13 1.17
KLA/ATP .64 .68 .85 .70 .91 1.10 1.03
Polr2j
KLA  ATP  ATP+KLA
 NM_011293 polymerase (RNA) II (DNA directed) polypeptide J (Polr2j), mRNA [NM_011293] KLA .96 .89 .88 1.01 .88 .92 .85
ATP 1.09 1.12 1.38 1.58 1.39 1.15 .89
KLA/ATP 1.05 1.05 1.46 1.33 1.51 1.25 .88
Polr2l
KLA  ATP  ATP+KLA
 XM_888022 gb|PREDICTED: Mus musculus polymerase (RNA) II (DNA directed) polypeptide L (Polr2l), mRNA [XM_888022] KLA .82 .92 .85 .82 .77 .73 .88
ATP .95 1.00 1.15 1.42 1.20 .91 .99
KLA/ATP .86 .89 1.04 1.23 1.25 .91 .59
Polr3a
KLA  ATP  ATP+KLA
 AK039440 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330043C08 product:hypothetical protein, full insert sequence. [AK039440] KLA 1.02 .94 .96 .97 1.13 .97 1.02
ATP .71 .55 .59 .69 .88 .93 .94
KLA/ATP .81 .65 .65 .80 .83 .88 .75
Polr3a
KLA  ATP  ATP+KLA
 NM_001081247 polymerase (RNA) III (DNA directed) polypeptide A (Polr3a), mRNA [NM_001081247] KLA 1.16 1.20 1.27 1.15 1.26 1.17 1.32
ATP .98 1.08 1.07 .92 .80 .99 1.26
KLA/ATP 1.22 1.30 1.18 .99 .78 1.24 1.27
Polr3b
KLA  ATP  ATP+KLA
 NM_027423 polymerase (RNA) III (DNA directed) polypeptide B (Polr3b), mRNA [NM_027423] KLA 1.03 1.05 1.02 1.07 1.11 1.15 1.05
ATP 1.09 1.15 .96 .97 .73 .75 .93
KLA/ATP 1.04 1.12 1.00 1.00 .74 .75 .77
Polr3c
KLA  ATP  ATP+KLA
 XM_131049 gb|PREDICTED: Mus musculus polymerase (RNA) III (DNA directed) polypeptide C, transcript variant 1 (Polr3c), mRNA [XM_131049] KLA 2.33 2.34 2.59 2.37 2.10 1.82 1.42
ATP 1.02 .97 1.12 1.19 .99 1.10 1.14
KLA/ATP 2.34 2.54 2.70 2.54 2.18 1.75 1.88
Polr3d
KLA  ATP  ATP+KLA
 NM_025945 polymerase (RNA) III (DNA directed) polypeptide D (Polr3d), mRNA [NM_025945] KLA 1.08 1.08 .90 .88 .98 .99 1.60
ATP .95 1.00 .94 .89 1.23 1.19 1.21
KLA/ATP 1.06 1.13 .88 .82 .68 .72 .55
Polr3e
KLA  ATP  ATP+KLA
 AK162059 adult male adrenal gland cDNA, RIKEN full-length enriched library, clone:7330401M11 product:sex-lethal interactor homolog (Drosophila), full insert sequence [AK162059] KLA .48 .46 .37 .33 .47 .53 .72
ATP 1.06 .96 .57 .49 .65 .27 .29
KLA/ATP .54 .43 .28 .37 .44 .27 .18
Polr3e
KLA  ATP  ATP+KLA
 NM_025298 polymerase (RNA) III (DNA directed) polypeptide E (Polr3e), mRNA [NM_025298] KLA .66 .69 .61 .58 .65 .72 1.37
ATP 1.01 .95 .80 .74 .58 .58 1.01
KLA/ATP .71 .69 .52 .57 .46 .42 .49
Polr3f
KLA  ATP  ATP+KLA
 NM_029763 polymerase (RNA) III (DNA directed) polypeptide F (Polr3f), mRNA [NM_029763] KLA 1.10 1.09 1.09 .98 .95 1.00 1.08
ATP 1.07 1.06 .84 .69 .72 .94 1.06
KLA/ATP 1.13 1.08 .80 .71 .70 .92 .92
Polr3g
KLA  ATP  ATP+KLA
 NM_001081176 polymerase (RNA) III (DNA directed) polypeptide G (Polr3g), mRNA [NM_001081176] KLA .51 .53 .43 .45 .41 .45 .57
ATP .90 .84 .68 .55 .54 .64 .60
KLA/ATP .51 .47 .46 .50 .48 .53 .46
Polr3gl
KLA  ATP  ATP+KLA
 NM_027241 polymerase (RNA) III (DNA directed) polypeptide G like (Polr3gl), mRNA [NM_027241] KLA .60 .51 .54 .55 .57 .70 .53
ATP .99 .86 1.08 .84 .48 .57 .69
KLA/ATP .55 .49 .64 .50 .53 .57 .67
Polr3h
KLA  ATP  ATP+KLA
 NM_030229 polymerase (RNA) III (DNA directed) polypeptide H (Polr3h), mRNA [NM_030229] KLA .89 .85 .75 .81 .76 .85 1.01
ATP .93 .81 .86 .71 .70 .93 .83
KLA/ATP .75 .78 .73 .70 .69 .76 .76
Polr3k
KLA  ATP  ATP+KLA
 NM_025901 polymerase (RNA) III (DNA directed) polypeptide K (Polr3k), mRNA [NM_025901] KLA .72 .72 .66 .69 .63 .74 .85
ATP .87 .84 1.14 .92 .64 .87 .72
KLA/ATP .65 .71 .90 .74 .65 .53 .44
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Psmc1
KLA  ATP  ATP+KLA
 NM_008947 protease (prosome, macropain) 26S subunit, ATPase 1 (Psmc1), mRNA [NM_008947] KLA .77 .81 .78 .77 .96 1.40 1.65
ATP .98 1.02 .93 .98 1.01 1.61 1.77
KLA/ATP .83 .78 .71 .72 .83 1.58 2.21
Psmc2
KLA  ATP  ATP+KLA
 AK083989 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130073K11 product:proteasome (prosome, macropain) 26S subunit, ATPase 2, full insert sequence. [AK083989] KLA .98 .99 .95 .94 1.12 1.15 1.15
ATP .95 .83 .73 .80 1.17 1.17 .98
KLA/ATP .94 .88 .77 .93 1.04 1.02 .96
Psmc2
KLA  ATP  ATP+KLA
 NM_011188 proteasome (prosome, macropain) 26S subunit, ATPase 2 (Psmc2), mRNA [NM_011188] KLA 1.00 .97 1.00 1.04 1.16 1.36 1.63
ATP 1.14 1.04 .91 .91 .94 1.25 1.26
KLA/ATP 1.06 1.05 1.05 .97 .98 1.01 1.33
Psmc3
KLA  ATP  ATP+KLA
 NM_008948 proteasome (prosome, macropain) 26S subunit, ATPase 3 (Psmc3), mRNA [NM_008948] KLA .97 1.03 .97 .90 .99 .98 1.14
ATP 1.03 1.03 .85 1.10 1.00 .96 1.01
KLA/ATP 1.00 1.02 .85 1.04 .84 .84 .94
Psmc4
KLA  ATP  ATP+KLA
 NM_011874 proteasome (prosome, macropain) 26S subunit, ATPase, 4 (Psmc4), mRNA [NM_011874] KLA 1.08 1.20 1.14 1.27 1.37 1.27 1.57
ATP 1.06 1.10 .98 1.24 1.20 1.15 1.25
KLA/ATP 1.21 1.29 1.25 1.45 1.19 1.18 1.43
Psmc5
KLA  ATP  ATP+KLA
 NM_008950 protease (prosome, macropain) 26S subunit, ATPase 5 (Psmc5), mRNA [NM_008950] KLA 1.11 1.15 1.12 1.02 1.27 1.38 1.70
ATP 1.05 1.12 .93 1.31 1.24 1.19 1.41
KLA/ATP 1.21 1.26 .98 1.49 1.12 1.17 1.42
Psmc6
KLA  ATP  ATP+KLA
 BC043044 proteasome (prosome, macropain) 26S subunit, ATPase, 6, mRNA (cDNA clone IMAGE:5701431), partial cds [BC043044] KLA 1.42 1.35 1.26 1.08 1.05 .99 1.08
ATP 1.09 1.01 1.38 .90 .94 .76 .82
KLA/ATP 1.17 1.25 1.53 .99 .91 .76 .57
Psmc6
KLA  ATP  ATP+KLA
 NM_025959 proteasome (prosome, macropain) 26S subunit, ATPase, 6 (Psmc6), mRNA [NM_025959] KLA 1.02 1.00 .96 .91 .88 1.07 1.62
ATP .97 .94 1.04 .89 1.07 1.40 1.16
KLA/ATP .97 .98 .98 .81 .95 1.07 1.13
Psmd1
KLA  ATP  ATP+KLA
 NM_027357 proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 (Psmd1), mRNA [NM_027357] KLA .74 .83 .77 .69 .77 .92 1.20
ATP 1.11 1.16 1.00 1.02 1.05 1.22 1.31
KLA/ATP .92 .89 .76 .78 .74 .84 1.09
Psmd11
KLA  ATP  ATP+KLA
 AK007029 adult male testis cDNA, RIKEN full-length enriched library, clone:1700089D09 product:unclassifiable, full insert sequence. [AK007029] KLA .96 1.04 1.01 1.05 1.00 1.06 .97
ATP .91 1.04 1.01 1.12 1.07 1.05 1.07
KLA/ATP .98 1.01 1.08 1.00 1.06 .96 .95
Psmd11
KLA  ATP  ATP+KLA
 AK157616 activated spleen cDNA, RIKEN full-length enriched library, clone:F830226O03 product:unclassifiable, full insert sequence. [AK157616] KLA 1.10 1.12 1.06 1.17 1.13 1.29 1.37
ATP .89 1.11 1.06 .97 1.14 1.52 1.17
KLA/ATP 1.10 1.14 1.19 1.13 1.11 1.30 1.33
Psmd11
KLA  ATP  ATP+KLA
 NM_178616 proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 (Psmd11), mRNA [NM_178616] KLA 1.26 1.27 1.18 1.29 1.32 1.64 1.65
ATP 1.09 1.07 1.08 .90 1.49 2.82 1.78
KLA/ATP 1.38 1.32 1.40 1.39 1.29 1.75 2.29
Psmd12
KLA  ATP  ATP+KLA
 NM_025894 proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 (Psmd12), mRNA [NM_025894] KLA 1.04 1.05 1.00 1.06 1.18 1.42 1.41
ATP .93 .98 1.00 1.07 1.12 1.28 1.45
KLA/ATP .96 1.01 .96 1.02 1.02 1.37 1.23
Psmd13
KLA  ATP  ATP+KLA
 NM_011875 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 (Psmd13), mRNA [NM_011875] KLA 1.11 1.16 1.02 1.21 1.26 1.35 1.36
ATP 1.03 1.11 .96 1.09 1.14 1.06 1.19
KLA/ATP 1.09 1.22 1.24 1.18 1.13 .98 1.47
Psmd14
KLA  ATP  ATP+KLA
 AK053099 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930049P07 product:unclassifiable, full insert sequence [AK053099] KLA .96 .99 .96 1.01 1.00 .98 .97
ATP 1.00 .90 .95 1.00 1.12 1.01 .93
KLA/ATP 1.01 .93 .96 .96 .95 .94 .99
Psmd14
KLA  ATP  ATP+KLA
 NM_021526 proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 (Psmd14), mRNA [NM_021526] KLA 1.20 1.23 1.30 1.14 1.13 1.11 1.36
ATP 1.02 .97 1.06 1.01 1.09 1.58 1.15
KLA/ATP 1.19 1.23 1.22 1.05 .98 1.07 1.11
Psmd2
KLA  ATP  ATP+KLA
 NM_134101 proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 (Psmd2), mRNA [NM_134101] KLA 1.00 1.00 1.07 .89 1.11 1.12 1.39
ATP 1.09 1.19 .99 1.03 1.02 1.07 1.53
KLA/ATP 1.09 1.11 .95 .98 .80 .97 1.48
Psmd3
KLA  ATP  ATP+KLA
 NM_009439 proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 (Psmd3), mRNA [NM_009439] KLA .98 1.01 .91 .98 1.04 1.40 1.52
ATP .97 .91 1.01 .86 .87 1.10 1.18
KLA/ATP .94 .95 .95 .85 .93 .88 .99
Psmd4
KLA  ATP  ATP+KLA
 AB029144 mRNA for pUb-R3, complete cds. [AB029144] KLA 1.20 1.00 1.07 1.07 1.43 1.48 1.29
ATP 1.26 1.30 1.25 .95 1.58 2.04 1.34
KLA/ATP 1.11 1.23 1.31 .88 1.30 1.58 1.67
Psmd4
KLA  ATP  ATP+KLA
 NM_008951 proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 (Psmd4), mRNA [NM_008951] KLA 1.11 1.15 1.08 1.12 1.22 1.15 1.32
ATP 1.07 1.11 .99 1.18 1.18 1.12 1.43
KLA/ATP 1.11 1.24 1.12 1.26 1.13 1.12 1.61
Psmd6
KLA  ATP  ATP+KLA
 NM_025550 proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 (Psmd6), mRNA [NM_025550] KLA 1.19 1.23 1.16 1.23 1.34 1.02 1.14
ATP 1.01 1.08 1.00 .88 .83 1.08 .88
KLA/ATP 1.17 1.15 1.22 1.19 .95 .86 .88
Psmd7
KLA  ATP  ATP+KLA
 AK158379 adult inner ear cDNA, RIKEN full-length enriched library, clone:F930111J18 product:proteasome (prosome, macropain) 26S subunit, non-ATPase, 7, full insert sequence. [AK158379] KLA 1.06 .97 1.07 1.03 1.44 1.28 1.30
ATP .85 .73 .76 .76 1.79 1.59 1.03
KLA/ATP .90 .77 .74 .79 1.32 1.15 1.03
Psmd7
KLA  ATP  ATP+KLA
 NM_010817 proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 (Psmd7), mRNA [NM_010817] KLA 1.38 1.41 1.39 1.45 1.38 1.57 1.64
ATP 1.04 1.09 .93 .85 1.01 1.69 1.26
KLA/ATP 1.36 1.46 1.46 1.39 1.10 1.30 1.36
Psmd8
KLA  ATP  ATP+KLA
 NM_026545 proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 (Psmd8), mRNA [NM_026545] KLA 1.04 1.02 1.17 1.00 1.02 1.00 .98
ATP 1.06 1.17 1.13 1.39 1.54 1.43 1.21
KLA/ATP 1.13 1.13 1.01 1.38 1.40 1.64 1.39
Ptma
KLA  ATP  ATP+KLA
 NM_008972 prothymosin alpha (Ptma), mRNA [NM_008972] KLA 1.11 1.09 1.08 1.08 .99 .77 .50
ATP 1.08 1.08 1.23 1.74 1.49 .88 .41
KLA/ATP 1.08 1.19 1.28 1.62 1.61 1.07 .30
Ran
KLA  ATP  ATP+KLA
 NM_009391 RAN, member RAS oncogene family (Ran), mRNA [NM_009391] KLA .96 1.03 .96 .88 .78 .61 .75
ATP .96 .96 1.04 .87 1.10 1.18 .64
KLA/ATP .96 .97 .99 .84 1.03 .91 .61
Rasl2-9
KLA  ATP  ATP+KLA
 NM_009028 RAS-like, family 2, locus 9 (Rasl2-9), mRNA [NM_009028] KLA .94 1.01 1.05 .89 .81 .62 .70
ATP 1.05 1.05 1.13 .99 1.25 1.24 .68
KLA/ATP 1.00 .98 1.12 .94 1.10 .90 .67
Rb1
KLA  ATP  ATP+KLA
 NM_009029 retinoblastoma 1 (Rb1), mRNA [NM_009029] KLA .67 .60 .55 .51 .46 .75 .79
ATP 1.04 1.01 1.12 .86 .59 .43 .76
KLA/ATP .64 .59 .58 .46 .36 .30 .65
Rbpj
KLA  ATP  ATP+KLA
 NM_009035 recombination signal binding protein for immunoglobulin kappa J region (Rbpj), transcript variant 1, mRNA [NM_009035] KLA .92 .88 1.03 1.33 1.65 1.48 .97
ATP 1.07 1.10 1.09 1.18 1.35 1.61 1.23
KLA/ATP .86 .86 .82 1.03 .70 .77 1.46
Rbpjl
KLA  ATP  ATP+KLA
 NM_009036 recombination signal binding protein for immunoglobulin kappa J region-like (Rbpjl), mRNA [NM_009036] KLA .94 .98 .94 .99 1.07 1.02 1.02
ATP .97 .96 1.10 1.27 1.05 1.10 .98
KLA/ATP 1.00 1.02 1.00 .95 .96 .94 1.01
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Relb
KLA  ATP  ATP+KLA
 NM_009046 avian reticuloendotheliosis viral (v-rel) oncogene related B (Relb), mRNA [NM_009046] KLA 4.39 4.46 3.54 3.47 4.36 3.18 2.72
ATP 1.01 1.07 1.23 2.66 3.23 3.50 1.24
KLA/ATP 4.43 4.52 3.56 4.10 2.85 2.92 3.30
Ripk1
KLA  ATP  ATP+KLA
 NM_009068 receptor (TNFRSF)-interacting serine-threonine kinase 1 (Ripk1), mRNA [NM_009068] KLA 1.32 1.33 1.50 1.09 1.00 1.11 1.13
ATP .98 .94 .60 .59 1.35 1.56 1.45
KLA/ATP 1.48 1.30 1.01 1.05 1.36 1.53 1.37
Rpo1-1
KLA  ATP  ATP+KLA
 NM_009085 RNA polymerase 1-1 (Rpo1-1), mRNA [NM_009085] KLA .77 .81 .81 .91 .90 .68 .86
ATP 1.03 .92 .86 .94 2.06 1.70 .91
KLA/ATP .82 .85 .86 .65 1.41 1.49 .92
Rpo1-3
KLA  ATP  ATP+KLA
 NM_009087 RNA polymerase 1-3 (Rpo1-3), transcript variant 1, mRNA [NM_009087] KLA 1.00 .98 .86 .90 .95 .76 .93
ATP 1.07 1.09 1.20 1.26 1.26 1.12 .99
KLA/ATP .89 1.04 1.10 1.08 1.01 .71 .67
Rpo1-3
KLA  ATP  ATP+KLA
 NM_181730 RNA polymerase 1-3 (Rpo1-3), transcript variant 2, mRNA [NM_181730] KLA 1.06 1.17 1.07 1.08 .99 1.04 .98
ATP .93 .97 1.12 1.27 1.36 1.31 .82
KLA/ATP 1.02 1.06 1.20 1.31 1.28 1.32 .90
Sfpi1
KLA  ATP  ATP+KLA
 NM_011355 SFFV proviral integration 1 (Sfpi1), mRNA [NM_011355] KLA 2.54 2.77 2.96 2.31 3.22 2.44 2.29
ATP 1.17 1.55 .79 1.96 1.49 1.23 1.66
KLA/ATP 3.35 3.40 1.30 3.78 1.70 1.80 3.18
Shfm1
KLA  ATP  ATP+KLA
 NM_009169 split hand/foot malformation (ectrodactyly) type 1 (Shfm1), mRNA [NM_009169] KLA 1.04 1.01 .96 1.15 1.07 1.17 1.15
ATP .92 .88 1.07 .98 1.00 1.07 1.07
KLA/ATP .90 .94 1.19 1.11 1.25 1.23 1.08
Skp2
KLA  ATP  ATP+KLA
 AF083215 SCF complex protein Skp2 mRNA, complete cds. [AF083215] KLA .36 .37 .34 .37 .44 .78 .60
ATP 1.05 1.35 .85 .66 .83 .54 .76
KLA/ATP .33 .39 .37 .37 .65 .73 .62
Snd1
KLA  ATP  ATP+KLA
 NM_019776 staphylococcal nuclease and tudor domain containing 1 (Snd1), mRNA [NM_019776] KLA 1.58 1.66 1.88 1.68 1.84 1.62 1.19
ATP 1.11 1.16 .69 .91 .64 .70 .93
KLA/ATP 1.86 1.76 1.28 1.41 .78 1.05 .98
Snw1
KLA  ATP  ATP+KLA
 NM_025507 SNW domain containing 1 (Snw1), mRNA [NM_025507] KLA 2.06 2.04 2.00 2.32 1.97 1.86 1.63
ATP 1.12 1.08 1.10 1.02 1.17 1.61 1.60
KLA/ATP 1.90 2.12 2.63 2.35 2.27 2.75 2.79
Spn
KLA  ATP  ATP+KLA
 AK041480 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630014B01 product:sialophorin, full insert sequence. [AK041480] KLA .95 1.02 .97 1.05 1.02 1.06 1.02
ATP 1.05 .97 1.00 1.02 1.05 .97 1.00
KLA/ATP 1.03 .97 .89 1.05 1.05 1.06 .94
Spn
KLA  ATP  ATP+KLA
 NM_009259 sialophorin (Spn), transcript variant 1, mRNA [NM_009259] KLA .98 1.00 1.05 1.05 .96 .77 .38
ATP 1.06 .98 1.25 1.17 .91 .67 .22
KLA/ATP .95 .96 1.35 .96 .90 .52 .22
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Syk
KLA  ATP  ATP+KLA
 NM_011518 spleen tyrosine kinase (Syk), mRNA [NM_011518] KLA 2.48 2.59 2.57 2.26 3.29 3.75 3.19
ATP .96 .85 .59 1.01 2.80 3.77 2.11
KLA/ATP 2.56 2.09 1.16 1.35 2.50 4.33 5.10
Tbk1
KLA  ATP  ATP+KLA
 NM_019786 TANK-binding kinase 1 (Tbk1), mRNA [NM_019786] KLA 2.55 2.76 3.22 2.67 2.56 2.29 1.96
ATP 1.13 1.30 1.12 1.07 1.29 1.41 1.40
KLA/ATP 2.84 3.17 2.58 2.43 1.70 2.15 2.37
Tbp
KLA  ATP  ATP+KLA
 NM_013684 TATA box binding protein (Tbp), mRNA [NM_013684] KLA 1.27 1.33 1.42 1.17 1.23 1.20 1.22
ATP 1.07 1.21 1.01 .85 .93 1.04 1.14
KLA/ATP 1.38 1.40 1.13 1.11 .93 1.13 1.12
Tbpl1
KLA  ATP  ATP+KLA
 AK028621 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732418P20 product:TATA box binding protein-like protein, full insert sequence [AK028621] KLA 1.03 1.11 .99 .98 .97 .88 .92
ATP .95 1.03 1.05 .94 .94 .96 1.09
KLA/ATP .98 .95 .99 .98 .98 1.03 1.01
Tbpl1
KLA  ATP  ATP+KLA
 NM_011603 TATA box binding protein-like 1 (Tbpl1), mRNA [NM_011603] KLA .68 .72 .72 .71 .76 .87 1.05
ATP .93 .97 .98 .89 1.05 .97 .85
KLA/ATP .67 .66 .74 .70 1.04 1.20 1.00
Tbpl2
KLA  ATP  ATP+KLA
 NM_199059 TATA box binding protein like 2 (Tbpl2), mRNA [NM_199059] KLA 1.01 1.10 .97 1.00 .92 .96 1.04
ATP 1.01 1.03 1.04 1.02 .95 1.00 1.02
KLA/ATP 1.04 .92 .83 1.06 1.03 1.02 .97
Tnfaip3
KLA  ATP  ATP+KLA
 NM_009397 tumor necrosis factor, alpha-induced protein 3 (Tnfaip3), mRNA [NM_009397] KLA 29.69 27.73 21.42 18.86 14.42 8.13 7.48
ATP 1.73 4.86 21.57 43.06 30.03 18.86 8.31
KLA/ATP 29.39 35.88 40.64 52.71 33.19 25.38 17.75
Tradd
KLA  ATP  ATP+KLA
 NM_001033161 TNFRSF1A-associated via death domain (Tradd), mRNA [NM_001033161] KLA .77 .71 .82 .89 .89 1.11 1.06
ATP 1.00 .90 1.01 .73 .59 1.34 1.50
KLA/ATP .79 .73 .83 .63 .72 1.11 1.73
Traf1
KLA  ATP  ATP+KLA
 NM_009421 Tnf receptor-associated factor 1 (Traf1), mRNA [NM_009421] KLA 44.86 39.03 38.11 34.21 36.49 19.69 14.75
ATP 1.14 1.04 1.98 8.16 16.79 30.81 6.36
KLA/ATP 46.20 45.67 45.63 38.00 27.26 31.47 63.83
Traf2
KLA  ATP  ATP+KLA
 NM_009422 Tnf receptor-associated factor 2 (Traf2), mRNA [NM_009422] KLA 3.38 3.62 3.49 3.36 3.49 3.39 2.68
ATP .97 1.04 1.00 1.10 1.54 2.40 1.55
KLA/ATP 3.38 3.16 2.93 2.74 2.67 3.11 4.70
Traf3
KLA  ATP  ATP+KLA
 NM_011632 Tnf receptor-associated factor 3 (Traf3), transcript variant 1, mRNA [NM_011632] KLA .52 .49 .51 .49 .80 .98 1.22
ATP .93 .92 .95 1.13 2.70 1.80 1.42
KLA/ATP .56 .50 .49 1.07 2.94 1.92 1.65
Traf5
KLA  ATP  ATP+KLA
 NM_011633 Tnf receptor-associated factor 5 (Traf5), mRNA [NM_011633] KLA 1.82 1.92 1.93 2.10 2.75 2.08 1.00
ATP 1.02 1.04 1.10 .78 3.79 2.22 1.42
KLA/ATP 1.70 1.89 1.85 1.64 5.40 2.10 1.83
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09
Usp7
KLA  ATP  ATP+KLA
 BC022588 ubiquitin specific peptidase 7, mRNA (cDNA clone IMAGE:4036999), **** WARNING: chimeric clone ****. [BC022588] KLA 1.29 1.16 1.15 1.01 1.20 1.07 1.01
ATP 1.22 1.35 1.25 1.13 1.42 1.03 .90
KLA/ATP 1.83 1.81 1.43 1.18 1.31 1.00 .89
Usp7
KLA  ATP  ATP+KLA
 NM_001003918 ubiquitin specific peptidase 7 (Usp7), mRNA [NM_001003918] KLA 1.49 1.46 1.42 1.41 1.07 .91 .91
ATP 1.01 .91 .90 .68 1.07 1.37 .87
KLA/ATP 1.45 1.50 1.44 .92 1.13 1.07 .73
Vim
KLA  ATP  ATP+KLA
 AK033175 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030453F01 product:vimentin, full insert sequence [AK033175] KLA .85 .89 .81 .91 .96 1.02 1.21
ATP 2.48 3.18 3.05 2.25 1.14 .86 1.13
KLA/ATP 1.07 1.60 1.38 1.46 .91 .79 1.12
Vim
KLA  ATP  ATP+KLA
 NM_011701 vimentin (Vim), mRNA [NM_011701] KLA 1.01 .99 1.04 .94 .78 .66 1.03
ATP 1.01 1.12 1.25 1.54 1.48 1.33 1.01
KLA/ATP .95 .98 .89 1.14 .98 .92 .66
Xpo1
KLA  ATP  ATP+KLA
 NM_134014 exportin 1, CRM1 homolog (yeast) (Xpo1), transcript variant 1, mRNA [NM_134014] KLA .85 .84 .92 .94 1.07 1.07 .94
ATP 1.00 .97 .86 .74 .61 .56 .77
KLA/ATP .87 .81 .71 .66 .70 .74 .77
Ywhab
KLA  ATP  ATP+KLA
 NM_018753 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (Ywhab), mRNA [NM_018753] KLA 1.03 1.15 1.18 1.10 1.20 1.20 1.23
ATP 1.02 1.08 .84 1.06 1.08 1.24 1.24
KLA/ATP 1.15 1.18 .82 1.17 .91 1.24 1.58
Ywhae
KLA  ATP  ATP+KLA
 NM_009536 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (Ywhae), mRNA [NM_009536] KLA 1.32 1.35 1.43 1.40 1.46 1.45 1.19
ATP 1.09 1.30 1.21 1.51 1.16 .97 1.01
KLA/ATP 1.45 1.50 1.33 1.85 1.25 1.16 1.08
Ywhag
KLA  ATP  ATP+KLA
 NM_018871 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (Ywhag), mRNA [NM_018871] KLA .87 .96 .92 .89 1.14 1.30 1.77
ATP 1.08 1.22 .86 .83 .91 1.46 1.09
KLA/ATP 1.05 1.04 .61 .72 .76 1.44 1.52
Ywhah
KLA  ATP  ATP+KLA
 NM_011738 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide (Ywhah), mRNA [NM_011738] KLA .55 .54 .49 .44 .38 .58 .70
ATP .99 .93 1.14 .81 .62 .53 1.07
KLA/ATP .54 .52 .54 .35 .37 .35 .68
Ywhaq
KLA  ATP  ATP+KLA
 AK037746 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130046D12 product:unclassifiable, full insert sequence [AK037746] KLA .97 .93 .94 .95 .97 .96 .95
ATP 1.09 1.07 1.44 1.49 1.04 1.01 .96
KLA/ATP 1.04 .96 1.11 1.36 1.01 1.03 .87
Ywhaq
KLA  ATP  ATP+KLA
 NM_011739 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (Ywhaq), mRNA [NM_011739] KLA .93 .98 .96 .99 .92 .76 .88
ATP 1.07 1.08 1.01 1.35 1.37 1.28 .70
KLA/ATP .97 1.04 .94 1.17 1.09 1.18 .77
Ywhaz
KLA  ATP  ATP+KLA
 AK050511 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820005J08 product:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, full insert sequence. [AK050511] KLA .99 .96 .97 .96 1.00 .95 .96
ATP .99 1.00 .98 1.01 1.04 .94 1.01
KLA/ATP .99 .97 1.00 .98 .88 .97 1.01
Ywhaz
KLA  ATP  ATP+KLA
 NM_011740 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), mRNA [NM_011740] KLA 1.79 1.86 1.98 2.10 2.11 2.10 1.30
ATP 1.00 1.21 .95 1.37 1.21 1.42 1.08
KLA/ATP 1.73 1.92 1.58 2.28 1.68 1.76 1.47